Urology

Millions of people each year find themselves compromised by Urological Disorders. Syner-Med is committed to the development of therapies and treatments in the field of Urology. Today we have an array of products covering Stress Urinary Incontinence (SUI) to Recurrent Urinary Tract Infections (RUTI).

Hyacyst® (sodium hyaluronate)

Hyacyst® (sodium hyaluronate) is a bladder instillation indicated for the temporary replenishment of the GAG layer in the following bladder conditions; interstitial cystitis (IC), painful bladder syndrome (PBS), haemorrhagic cystitis, recurrent bacterial cystitis, radiation induced cystitis and chemotherapy induced cystitis.

Hyacyst® (sodium hyaluronate) is available in strengths of 40mg/50ml and 120mg/50ml which are supplied as Pre-Filled Syringes (PFS) or Vials. Hyacyst® PFS packs include a catheter adaptor to enable Hyacyst® PFS to be used with a wide variety of available catheters, making them suitable for self-instillation at home.

Hyacyst® (sodium hyaluronate) is approved for prescribing in the Community on FP10 prescriptions in the UK.

Read more for SPC/IFU and prescribing information

Dexell® (positively charged diethylaminoethanol dextranomer microspheres)

Dexell® (positively charged diethylaminoethanol dextranomer microspheres) is a bulking agent indicated for the endoscopic treatment of vesicoureteral reflux (VUR) in children and stress urinary incontinence (SUI).

Dexell® (positively charged diethylaminoethanol dextranomer microspheres) consists of positively charged diethylaminoethanol (DEAE) dextranomer microspheres (active ingredient) suspended in a cross linked hyaluronic acid gel solution (transporter). Both the dextranomer microspheres and hyaluronate gel are biocompatible, non-immunogenic and bio-degradable.

Read more for SPC/IFU and prescribing information
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380
Subscribe to RSS - Urology

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com